Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In Phase 1 and 2a clinical trials, once-daily subcutaneous injections of RG7697 (0.252.5 mg) for 14 days in 56 patients with T2DM and 1.8 mg of RG7697 for 12 weeks in patients with T2DM who were poorly responsive to metformin reduced body weight and improved glycemic control
Accessed 11 June 2026
Walking in with knowledge about standard dosing protocols shows your provider that you have invested time in understanding the treatment
Increased fatty-acid availability is not identical to increased oxidation
Br J Pharmacol 49:602613 Jorup-Rnstrm C, Beermann B, Whlin-Boll E, Melander A, Britton S (1986) Reduction of paracetamol and aspirin metabolism during viral hepatitis
When treating pregnant patients with obesity, it is important to weigh the risks of obesity itself against any potential risks and benefits of prescribing a weight loss medication
US$ 27.63
US$ 23.76
US$ 20.20
US$ 20.82
US$ 29.65
US$ 29.39
